human health care company
Regulatory and legislative health care issues, including: 340B program; TRICARE Pharmacy Program; FDA Guidance on Alzheimer's drug development; Pharmaceutical Supply Chain; Drug Pricing; PDUFA Reauthorization. S.909, The Prescription Drug Price Relief Act; S.908, The Medicare Drug Price Negotiation Act; S.920, The Affordable and Safe Prescription Drug Importation Act; H.R.7667, Food and Drug Amendments of 2022; S.4348, FDASLA Act of 2022. General issues related to Medicare and Medicaid, including: Part D Medicare Program; Proposed Part B IPI Demonstration Project; Drug Pricing; Medicaid rebates and AMP Cap; CMS NCD for Alzheimer's Drugs. H.R.748, CARES Act (P.L.116-136) implementation; H.R.1319, American Rescue Plan Act of 2021 (P.L.117-2) implementation; H.R.1868, To prevent across-the-board direct spending cuts, and for other purposes; H.R.3, Elijah E. Cummings Lower Drug Costs Now Act; FY2022 Budget Reconciliation (H.R.5376). H.R.4479/S.2609, Facilitating Innovative Nuclear Diagnostics Act of 2021. Issues related to pharmaceutical IP and supply chain; S.1260, United States Innovation and Competition Act of 2021; H.R.4521, America COMPETES Act of 2022.
HCR - Health Issues MMM - Medicare/Medicaid TRD - Trade (domestic/foreign)
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
CROSSROADS STRATEGIES, LLC
800 North Capitol Street, NW, Suite 800, Washington, DC, 20002, US
MATHEW LAPINSKI JASON BENJAMIN VAN PELT BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI JASON BENJAMIN VAN PELT BRITTANY JOHNSON HERNANDEZ MATHEW LAPINSKI JASON BENJAMIN VAN PELT BRITTANY JOHNSON HERNANDEZ